A law firm is investigating claims against the manufacturers of popular heartburn and acid reflux drugs, alleging they could be responsible for causing stomach cancers and kidney failure in approximately 100,000 people.
A judge has dismissed a class action alleging Monsanto’s Roundup weed killer is carcinogenic but did not go so far as to say it definitively does not cause cancer, while also dressing down the lawyers for both sides for causing delays in the case.
The High Court has refused special leave in a failed class action against Volkswagen over allegedly defective Takata airbags.
US consumer goods giant 3M is facing a possible class action on behalf of members of the Australian Defence Force who allegedly suffered hearing loss from defective combat earplugs.
A judge has signed off on a bill that brings the total settlement administration costs in a class action against Johnson & Johnson unit De Puy to over $13 million, amid a push by some judges to open the settlement administration gig up to competition.
Defending allegations that its popular weed killer Roundup is carcinogenic, agrochemical giant Monsanto has accused the class action of having its “finger on the scales” when presenting scientific evidence to the court.
A class action against agrochemical giant Monsanto has told the court that there is “no safe level of exposure” to carcinogens allegedly present in the company’s popular weed killer Roundup.
As Johnson & Johnson loses its second attempt to use bankruptcy protection to resolve tens of thousands of US cases over its talcum powder products, a law firm has launched a class action investigation on behalf of Australian women who regularly used the powder and were later diagnosed with cancer.
A judge has told the law firm that has taken over a class action against Philips Electronics over recalled sleep apnea machines to take its time when amending the pleading, which he said was not the “finest piece of work” he’d ever seen.
A judge has signed off on almost $7.5 million in fees billed by the law firm behind the pelvic mesh class action against Boston Scientific, eight months after he approved the device maker’s $105 million settlement.